Transgene SA (OTCMKTS:TRGNF – Get Free Report) was the target of a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 4,349 shares. Based on an average daily volume of 282 shares, the days-to-cover ratio is presently 15.4 days.
Transgene Stock Performance
Shares of Transgene stock opened at $0.75 on Tuesday. The business has a 50-day moving average of $0.78 and a 200 day moving average of $0.87. Transgene has a 12 month low of $0.75 and a 12 month high of $0.80.
Transgene Company Profile
Transgene is a French biotechnology company that develops immunotherapies, with a primary focus on treatments for cancer. Its research centers on therapeutic vaccines and oncolytic viruses—engineered viruses designed to target tumors and stimulate an immune response. The company’s pipeline includes candidates using viral-vector platforms, including personalized approaches intended to tailor treatment to the characteristics of an individual patient’s tumor. Transgene advances its programs through research and clinical development, often working with academic and industry partners.
Featured Articles
- Five stocks we like better than Transgene
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Transgene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transgene and related companies with MarketBeat.com's FREE daily email newsletter.
